Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial".
Publication
, Journal Article
Harskamp, RE; Alexander, JH; Ferguson, TB; Hager, R; Mack, MJ; Englum, B; Wojdyla, D; Schulte, PJ; Kouchoukos, NT; de Winter, RJ; Gibson, CM ...
Published in: Circulation
May 24, 2016
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
May 24, 2016
Volume
133
Issue
21
Start / End Page
e665
Location
United States
Related Subject Headings
- Vascular Patency
- Transfection
- Saphenous Vein
- Mammary Arteries
- Internal Mammary-Coronary Artery Anastomosis
- Humans
- Graft Occlusion, Vascular
- Coronary Artery Bypass
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
Citation
APA
Chicago
ICMJE
MLA
NLM
Harskamp, R. E., Alexander, J. H., Ferguson, T. B., Hager, R., Mack, M. J., Englum, B., … Lopes, R. D. (2016). Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial". Circulation, 133(21), e665. https://doi.org/10.1161/CIRCULATIONAHA.116.022510
Harskamp, Ralf E., John H. Alexander, T Bruce Ferguson, Rebecca Hager, Michael J. Mack, Brian Englum, Daniel Wojdyla, et al. “Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial".” Circulation 133, no. 21 (May 24, 2016): e665. https://doi.org/10.1161/CIRCULATIONAHA.116.022510.
Harskamp RE, Alexander JH, Ferguson TB, Hager R, Mack MJ, Englum B, et al. Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial". Circulation. 2016 May 24;133(21):e665.
Harskamp, Ralf E., et al. “Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial".” Circulation, vol. 133, no. 21, May 2016, p. e665. Pubmed, doi:10.1161/CIRCULATIONAHA.116.022510.
Harskamp RE, Alexander JH, Ferguson TB, Hager R, Mack MJ, Englum B, Wojdyla D, Schulte PJ, Kouchoukos NT, de Winter RJ, Gibson CM, Peterson ED, Harrington RA, Smith PK, Lopes RD. Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial". Circulation. 2016 May 24;133(21):e665.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
May 24, 2016
Volume
133
Issue
21
Start / End Page
e665
Location
United States
Related Subject Headings
- Vascular Patency
- Transfection
- Saphenous Vein
- Mammary Arteries
- Internal Mammary-Coronary Artery Anastomosis
- Humans
- Graft Occlusion, Vascular
- Coronary Artery Bypass
- Cardiovascular System & Hematology
- 4207 Sports science and exercise